Skip to main content

Table 3 Clinicopathologic characteristics of canine mammary carcinoma

From: Overexpression of α-enolase correlates with poor survival in canine mammary carcinoma

  Quick score N P
  < 12 12   
Age     
< 11 years 13(81.3) 3(18.7) 16 1.000
11 years 27(81.8) 6(18.2) 33  
Ovariohysterectomy     
No 31(83.8) 6(16.2) 37 0.580
Yes 10(76.9) 3(23.1) 13  
Tumor Size     
T1 (< 3 cm) 15(93.8) 1(6.2) 16 0.298
T2 (3-5 cm) 13(72.2) 5(27.8) 18  
T3 (> 5 cm) 11(84.6) 2(15.4) 13  
Grade     
I 13(92.9) 1(7.1) 14 0.199
II/III 27(77.1) 8(22.9) 35  
Histological classification     
Carcinoma in benign tumor 4(80.0) 1(20.0) 5 0.566
Complex carcinoma 17(89.5) 2(10.5) 19  
Simple carcinoma 20(76.9) 6(23.1) 26  
Location of affected gland     
cranial 13(76.5) 4(23.5) 17 0.566
caudal 25(83.3) 5(16.7) 30  
ER     
Negative 22(81.5) 5(18.5) 27 1.000
Positive 19(82.6) 4(17.4) 23  
PR     
Negative 2(100.0) 0(0.0) 2 1.000
Positive 39(81.3) 9(18.7) 48  
HER2 Overexpression     
Negative 35(83.3) 7(16.7) 42 0.574
Positive 6(75.0) 2(25.0) 8  
ER with Quick score     
< 12 38(86.4) 6(13.6) 44 0.063
12 3(50.0) 3(50.0) 6  
  1. 1Tumor size measures maximum diameter